{"schema_version":"1","generated_at":"2026-11-03T08:08:16.180Z","data_as_of":null,"url":"https://www.findmykol.com/kol/matthew-koshy","json_url":"https://www.findmykol.com/kol/matthew-koshy/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"matthew-koshy","name":"Matthew Koshy","credential":"MD","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Illinois Chicago","institution_url":"https://www.findmykol.com/institution/university-of-illinois-chicago","city":"Chicago","state":"IL","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1568506103","orcid":"0000-0001-6937-7058","openalex":"A5001600608"},"summary":"Matthew Koshy is an Oncology physician affiliated with University of Illinois Chicago. OpenAlex indexes 212 publications with 6,106 citations (h-index 41).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":212,"cited_by_count":6106,"h_index":41,"latest_activity_year":2023,"source":"works"},"prescribing":{"data_year":2023,"areas_total":1,"areas_shown":1,"areas":[{"area":"Respiratory","share_pct":100,"classes_total":1,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":100,"drugs":[{"name":"Hydrocodone-Acetaminophen","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":2.7,"facility_pct":97.3},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"A phase 1 dose-escalation study of RiMO-301 with palliative radiation in advanced tumors.","year":2023,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.2527","status":"verified"},{"title":"Addressing Sex Disparities in Lung Cancer Screening Eligibility","year":2021,"journal":"CHEST Journal","source_url":"https://doi.org/10.1016/j.chest.2021.06.066","status":"verified"},{"title":"Machine Learning–Guided Adjuvant Treatment of Head and Neck Cancer","year":2020,"journal":"JAMA Network Open","source_url":"https://doi.org/10.1001/jamanetworkopen.2020.25881","status":"verified"},{"title":"Risk Prediction Model Versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing Race Disparities","year":2020,"journal":"Journal of Thoracic Oncology","source_url":"https://doi.org/10.1016/j.jtho.2020.08.006","status":"verified"},{"title":"Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis","year":2019,"journal":"Radiation Oncology","source_url":"https://doi.org/10.1186/s13014-019-1222-3","status":"verified"}],"source":"works"},"similar":[{"name":"Jerry Krishnan","slug":"jerry-krishnan","institution":"University of Illinois Chicago","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/jerry-krishnan","json_url":"https://www.findmykol.com/kol/jerry-krishnan/profile.json"},{"name":"John Daugirdas","slug":"john-daugirdas","institution":"University of Illinois Chicago","specialty":"Nephrology","url":"https://www.findmykol.com/kol/john-daugirdas","json_url":"https://www.findmykol.com/kol/john-daugirdas/profile.json"},{"name":"Niranjan Karnik","slug":"niranjan-karnik","institution":"University of Illinois Chicago","specialty":"Child & Adolescent Psychiatry","url":"https://www.findmykol.com/kol/niranjan-karnik","json_url":"https://www.findmykol.com/kol/niranjan-karnik/profile.json"},{"name":"Oana Danciu","slug":"oana-danciu","institution":"University of Illinois Chicago","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/oana-danciu","json_url":"https://www.findmykol.com/kol/oana-danciu/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}